Details for New Drug Application (NDA): 087893
✉ Email this page to a colleague
NDA 087893 describes SLO-BID, which is a drug marketed by Sanofi Aventis Us and is included in six NDAs. Additional details are available on the SLO-BID profile page.
The generic ingredient in SLO-BID is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
The generic ingredient in SLO-BID is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for 087893
| Tradename: | SLO-BID |
| Applicant: | Sanofi Aventis Us |
| Ingredient: | theophylline |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 087893
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 200MG | ||||
| Approval Date: | Jan 31, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
